Status unknown
Diagnostic Value of Serum Anti-CENPF Autoantibodies in Ground-Glass Nodule-Associated Lung Adenocarcinoma: A Multicenter Prospective Trial
- Sponsor
- Tangdu Hospital
- Enrolment
- 200 planned
- Conditions
- Lung cancer
- Interventions
- Postoperative pathology was the gold standard according to the 2021 edition of WHO"Pathological diagnostic criteria for lung tumors", which was finally approved by two senior pathologists; Serum autoantibodies against CENPF
- Registry
- ChiCTR2600129096
Full record on the Chinese Clinical Trial RegistrySource: WHO ICTRP, processed 3 August 2026
Primary outcomes
- The accuracy (AUC value) of serum anti-CENPF autoantibody levels in differentiating whether patients with imaging manifestations of GGN are invasive lung adenocarcinoma;
History
Last registry update
Registered
Started